Literature DB >> 25863735

Atrial fibrillation and rapid acute pacing regulate adipocyte/adipositas-related gene expression in the atria.

R K Chilukoti1, A Giese2, W Malenke2, G Homuth1, A Bukowska3, A Goette4, S B Felix5, J Kanaan6, H-G Wollert6, K Evert7, S Verheule8, P Jais9, S N Hatem10, U Lendeckel11, C Wolke2.   

Abstract

PURPOSE: Atrial fibrillation (AF) has been associated with increased volumes of epicardial fat and atrial adipocyte accumulation. Underlying mechanisms are not well understood. This study aims to identify rapid atrial pacing (RAP)/AF-dependent changes in atrial adipocyte/adipositas-related gene expression (AARE).
METHODS: Right atrial (RA) and adjacent epicardial adipose tissue (EAT) samples were obtained from 26 patients; 13 with AF, 13 in sinus rhythm (SR). Left atrial (LA) samples were obtained from 9 pigs (5 RAP, 4 sham-operated controls). AARE was analyzed using microarrays and RT-qPCR. The impact of diabetes/obesity on gene expression was additionally determined in RA samples (RAP ex vivo and controls) from 3 vs. 6 months old ZDF rats.
RESULTS: RAP in vivo of pigs resulted in substantial changes of AARE, with 66 genes being up- and 53 down-regulated on the mRNA level. Differential expression during adipocyte differentiation was confirmed using 3T3-L1 cells. In patients with AF (compared to SR), a comparable change in RA mRNA levels concerned a fraction of genes only (RETN, IGF1, HK2, PYGM, LOX, and NR4A3). RA and EAT were affected by AF to a different extent. In patients, concomitant disease contributes to AARE changes.
CONCLUSIONS: RAP, and to lesser extent AF, provoke significant changes in atrial AARE. In chronic AF, activation of this gene panel is very likely mediated by AF itself, AF risk factors and concomitant diseases. This may facilitate the development of an AF substrate by increasing atrial ectopic fat and fat infiltration of the atrial myocardium.
Copyright © 2015 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Adipocyte differentiation; Atrial adipositas; Atrial fibrillation; Structural remodeling

Mesh:

Substances:

Year:  2015        PMID: 25863735     DOI: 10.1016/j.ijcard.2015.03.072

Source DB:  PubMed          Journal:  Int J Cardiol        ISSN: 0167-5273            Impact factor:   4.164


  20 in total

Review 1.  Proteomics and transcriptomics in atrial fibrillation.

Authors:  Marc Sühling; Carmen Wolke; Christian Scharf; Uwe Lendeckel
Journal:  Herzschrittmacherther Elektrophysiol       Date:  2018-01-09

Review 2.  The role of epicardial adipose tissue in cardiac biology: classic concepts and emerging roles.

Authors:  Alexios S Antonopoulos; Charalambos Antoniades
Journal:  J Physiol       Date:  2017-03-13       Impact factor: 5.182

Review 3.  Insight into atrial fibrillation through analysis of the coding transcriptome in humans.

Authors:  Marja Steenman
Journal:  Biophys Rev       Date:  2020-07-15

Review 4.  EHRA/HRS/APHRS/SOLAECE expert consensus on atrial cardiomyopathies: Definition, characterization, and clinical implication.

Authors:  Andreas Goette; Jonathan M Kalman; Luis Aguinaga; Joseph Akar; Jose Angel Cabrera; Shih Ann Chen; Sumeet S Chugh; Domenico Corradi; Andre D'Avila; Dobromir Dobrev; Guilherme Fenelon; Mario Gonzalez; Stephane N Hatem; Robert Helm; Gerhard Hindricks; Siew Yen Ho; Brian Hoit; Jose Jalife; Young-Hoon Kim; Gregory Y H Lip; Chang-Sheng Ma; Gregory M Marcus; Katherine Murray; Akihiko Nogami; Prashanthan Sanders; William Uribe; David R Van Wagoner; Stanley Nattel
Journal:  Heart Rhythm       Date:  2016-06-10       Impact factor: 6.343

5.  Atrial natriuretic peptide regulates adipose tissue accumulation in adult atria.

Authors:  Nadine Suffee; Thomas Moore-Morris; Patrick Farahmand; Catherine Rücker-Martin; Gilles Dilanian; Magali Fradet; Daigo Sawaki; Geneviève Derumeaux; Pascal LePrince; Karine Clément; Isabelle Dugail; Michel Puceat; Stéphane N Hatem
Journal:  Proc Natl Acad Sci U S A       Date:  2017-01-17       Impact factor: 11.205

Review 6.  Mechanisms and Drug Development in Atrial Fibrillation.

Authors:  David Calvo; David Filgueiras-Rama; José Jalife
Journal:  Pharmacol Rev       Date:  2018-07       Impact factor: 25.468

7.  Fenofibrate inhibits atrial metabolic remodelling in atrial fibrillation through PPAR-α/sirtuin 1/PGC-1α pathway.

Authors:  Guang-Zhong Liu; Ting-Ting Hou; Yue Yuan; Peng-Zhou Hang; Jing-Jing Zhao; Li Sun; Guan-Qi Zhao; Jing Zhao; Jing-Mei Dong; Xiao-Bing Wang; Hang Shi; Yong-Wu Liu; Jing-Hua Zhou; Zeng-Xiang Dong; Yang Liu; Cheng-Chuang Zhan; Yue Li; Wei-Min Li
Journal:  Br J Pharmacol       Date:  2016-02-18       Impact factor: 8.739

Review 8.  Atrial Fibrillation Susceptibility in Obesity: An Excess Adiposity and Fibrosis Complicity?

Authors:  Sandeep V Pandit; Justus Anumonwo; José Jalife
Journal:  Circ Res       Date:  2016-05-13       Impact factor: 17.367

9.  Integration of "omics" techniques: Dronedarone affects cardiac remodeling in the infarction border zone.

Authors:  Ravi K Chilukoti; Josefine Lendeckel; Katrin Darm; Alicja Bukowska; Andreas Goette; Marc Sühling; Kirsten Utpatel; Barbara Peters; Georg Homuth; Uwe Völker; Carmen Wolke; Christian Scharf; Uwe Lendeckel
Journal:  Exp Biol Med (Maywood)       Date:  2018-07

Review 10.  Investigating interactions between epicardial adipose tissue and cardiac myocytes: what can we learn from different approaches?

Authors:  Katja Rietdorf; Hilary MacQueen
Journal:  Br J Pharmacol       Date:  2017-01-22       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.